Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 512

1.

Epigenetic priming sensitizes gastric cancer cells to irinotecan and cisplatin by restoring multiple pathways.

Moro H, Hattori N, Nakamura Y, Kimura K, Imai T, Maeda M, Yashiro M, Ushijima T.

Gastric Cancer. 2019 Sep 25. doi: 10.1007/s10120-019-01010-1. [Epub ahead of print]

PMID:
31555951
2.

FGF5 methylation is a sensitivity marker of esophageal squamous cell carcinoma to definitive chemoradiotherapy.

Iwabu J, Yamashita S, Takeshima H, Kishino T, Takahashi T, Oda I, Koyanagi K, Igaki H, Tachimori Y, Daiko H, Nakazato H, Nishiyama K, Lee YC, Hanazaki K, Ushijima T.

Sci Rep. 2019 Sep 16;9(1):13347. doi: 10.1038/s41598-019-50005-6.

3.

Significance of neoadjuvant chemoradiotherapy for borderline resectable pancreatic head cancer: Pathological local invasion and microvessel invasion analysis.

Naito Y, Ishikawa H, Sadashima E, Okabe Y, Takahashi K, Kawahara R, Hisaka T, Fukahori M, Ushijima T, Ishida Y, Tanigawa M, Mihara Y, Nakayama M, Kondo R, Kusano H, Takase Y, Abe H, Ogo E, Okuda K, Shimamatsu K, Yano H, Akiba J.

Mol Clin Oncol. 2019 Sep;11(3):225-233. doi: 10.3892/mco.2019.1885. Epub 2019 Jun 20.

4.

Successful off-pump surgical release for extrinsic compression of outflow graft obstruction of a left ventricular assist device.

Ushijima T, Tanoue Y, Mitsuo H, Shiose A.

Eur J Cardiothorac Surg. 2019 Aug 13. pii: ezz225. doi: 10.1093/ejcts/ezz225. [Epub ahead of print]

PMID:
31407774
5.

Metabolomic profiling reveals salivary hypotaurine as a potential early detection marker for medication-related osteonecrosis of the jaw.

Yatsuoka W, Ueno T, Miyano K, Uezono Y, Enomoto A, Kaneko M, Ota S, Soga T, Sugimoto M, Ushijima T.

PLoS One. 2019 Aug 12;14(8):e0220712. doi: 10.1371/journal.pone.0220712. eCollection 2019.

6.

Novel prodrugs of decitabine with greater metabolic stability and less toxicity.

Hattori N, Sako M, Kimura K, Iida N, Takeshima H, Nakata Y, Kono Y, Ushijima T.

Clin Epigenetics. 2019 Aug 1;11(1):111. doi: 10.1186/s13148-019-0709-y.

7.

Presacral malignant teratoid neoplasm in association with pathogenic DICER1 variation.

Nakano Y, Hasegawa D, Stewart DR, Schultz KAP, Harris AK, Hirato J, Uemura S, Tamura A, Saito A, Kawamura A, Yoshida M, Yamasaki K, Yamashita S, Ushijima T, Kosaka Y, Ichimura K, Dehner LP, Hill DA.

Mod Pathol. 2019 Jul 11. doi: 10.1038/s41379-019-0319-4. [Epub ahead of print]

PMID:
31296931
8.

Single-stage hybrid total arch replacement for extended arch aneurysms.

Oishi Y, Sonoda H, Ushijima T, Kimura S, Tatewaki H, Tanoue Y, Shiose A.

J Vasc Surg. 2019 Jun;69(6):1719-1725. doi: 10.1016/j.jvs.2018.08.184.

PMID:
31159980
9.

Cell-specific overexpression of COMT in dopaminergic neurons of Parkinson's disease.

Kuzumaki N, Suda Y, Iwasawa C, Narita M, Sone T, Watanabe M, Maekawa A, Matsumoto T, Akamatsu W, Igarashi K, Tamura H, Takeshima H, Tawfik VL, Ushijima T, Hattori N, Okano H, Narita M.

Brain. 2019 Jun 1;142(6):1675-1689. doi: 10.1093/brain/awz084.

PMID:
31135049
10.

Cancer cell niche factors secreted from cancer-associated fibroblast by loss of H3K27me3.

Maeda M, Takeshima H, Iida N, Hattori N, Yamashita S, Moro H, Yasukawa Y, Nishiyama K, Hashimoto T, Sekine S, Ishii G, Ochiai A, Fukagawa T, Katai H, Sakai Y, Ushijima T.

Gut. 2019 May 13. pii: gutjnl-2018-317645. doi: 10.1136/gutjnl-2018-317645. [Epub ahead of print]

PMID:
31085554
11.

Identification of a novel quinoline-based DNA demethylating compound highly potent in cancer cells.

Zwergel C, Schnekenburger M, Sarno F, Battistelli C, Manara MC, Stazi G, Mazzone R, Fioravanti R, Gros C, Ausseil F, Florean C, Nebbioso A, Strippoli R, Ushijima T, Scotlandi K, Tripodi M, Arimondo PB, Altucci L, Diederich M, Mai A, Valente S.

Clin Epigenetics. 2019 May 6;11(1):68. doi: 10.1186/s13148-019-0663-8.

12.

Three-Component Repurposed Technology for Enhanced Expression: Highly Accumulable Transcriptional Activators via Branched Tag Arrays.

Kunii A, Hara Y, Takenaga M, Hattori N, Fukazawa T, Ushijima T, Yamamoto T, Sakuma T.

CRISPR J. 2018 Oct;1:337-347. doi: 10.1089/crispr.2018.0009.

13.

Fhod1, an actin-organizing formin family protein, is dispensable for cardiac development and function in mice.

Sanematsu F, Kanai A, Ushijima T, Shiraishi A, Abe T, Kage Y, Sumimoto H, Takeya R.

Cytoskeleton (Hoboken). 2019 Feb;76(2):219-229. doi: 10.1002/cm.21523. Epub 2019 Apr 29.

PMID:
31008549
14.

LINC00162 confers sensitivity to 5-Aza-2'-deoxycytidine via modulation of an RNA splicing protein, HNRNPH1.

Zong L, Hattori N, Yasukawa Y, Kimura K, Mori A, Seto Y, Ushijima T.

Oncogene. 2019 Jun;38(26):5281-5293. doi: 10.1038/s41388-019-0792-8. Epub 2019 Mar 26.

PMID:
30914798
15.

[A Case of Chemotherapy-Induced Hyperammonemic Encephalopathy in a Patient with Metastatic Colon Cancer].

Tanaka T, Miwa K, Fukahori M, Yomoda T, Sakaue T, Nagasu S, Ushijima T, Koga H, Torimura T.

Gan To Kagaku Ryoho. 2019 Feb;46(2):259-262. Japanese.

PMID:
30914529
16.

DNA methylation genome-wide analysis in remnant and primary gastric cancers.

Sugimoto K, Ito T, Hulbert A, Chen C, Orita H, Maeda M, Moro H, Fukagawa T, Ushijima T, Katai H, Wada R, Sato K, Sakamoto K, Yu W, Considine M, Cope L, Brock MV.

Gastric Cancer. 2019 Mar 12. doi: 10.1007/s10120-019-00949-5. [Epub ahead of print]

PMID:
30863929
17.

Accumulation of genetic and epigenetic alterations in normal cells and cancer risk.

Takeshima H, Ushijima T.

NPJ Precis Oncol. 2019 Mar 6;3:7. doi: 10.1038/s41698-019-0079-0. eCollection 2019. Review.

18.

HeartMate II Implantation Via Single Incisional Ministernotomy in a Small Young Woman.

Ushijima T, Tanoue Y, Shiose A.

Innovations (Phila). 2019 Feb;14(1):80-83. doi: 10.1177/1556984519827696. Epub 2019 Feb 15.

PMID:
30848717
19.

A Novel Shape-Memory Monofilament Suture for Minimally Invasive Thoracoscopic Cardiac Surgery.

Seguchi R, Ishikawa N, Tarui T, Horikawa T, Ushijima T, Watanabe G.

Innovations (Phila). 2019 Feb;14(1):55-59. doi: 10.1177/1556984519828019. Epub 2019 Feb 20.

PMID:
30848715
20.

Eukaryotic peptide chain release factor 1 participates in translation termination of specific cysteine-poor prolamines in rice endosperm.

Elakhdar A, Ushijima T, Fukuda M, Yamashiro N, Kawagoe Y, Kumamaru T.

Plant Sci. 2019 Apr;281:223-231. doi: 10.1016/j.plantsci.2018.12.006. Epub 2018 Dec 12.

PMID:
30824055
21.

Glycosylation of ascites-derived exosomal CD133: a potential prognostic biomarker in patients with advanced pancreatic cancer.

Sakaue T, Koga H, Iwamoto H, Nakamura T, Ikezono Y, Abe M, Wada F, Masuda A, Tanaka T, Fukahori M, Ushijima T, Mihara Y, Naitou Y, Okabe Y, Kakuma T, Ohta K, Nakamura KI, Torimura T.

Med Mol Morphol. 2019 Feb 25. doi: 10.1007/s00795-019-00218-5. [Epub ahead of print]

PMID:
30805710
22.

The Origin of CIMP, At Last.

Ushijima T, Suzuki H.

Cancer Cell. 2019 Feb 11;35(2):165-167. doi: 10.1016/j.ccell.2019.01.015.

PMID:
30753821
23.

BRAF inhibitor: a novel therapy for ameloblastoma in mandible.

Abe M, Zong L, Abe T, Takeshima H, Ji J, Ushijima T, Hoshi K.

Chin J Cancer Res. 2018 Dec;30(6):677-678. doi: 10.21147/j.issn.1000-9604.2018.06.12. No abstract available.

24.

Identification of a metastatic lung adenocarcinoma of the palate mucosa through genetic and histopathological analysis: a rare case report and literature review.

Abe M, Watanabe K, Shinozaki-Ushiku A, Ushiku T, Abe T, Fujihara Y, Amano Y, Zong L, Wang CP, Kubo E, Inaki R, Kinoshita N, Yamashita S, Takai D, Ushijima T, Nagase T, Hoshi K.

BMC Cancer. 2019 Jan 11;19(1):52. doi: 10.1186/s12885-019-5277-1. Review.

25.

Invasive breast cancers in adolescent and young adult women show more aggressive immunohistochemical and clinical features than those in women aged 40-44 years.

Hironaka-Mitsuhashi A, Tsuda H, Yoshida M, Shimizu C, Asaga S, Hojo T, Tamura K, Kinoshita T, Ushijima T, Hiraoka N, Fujiwara Y.

Breast Cancer. 2019 May;26(3):386-396. doi: 10.1007/s12282-018-00937-0. Epub 2018 Dec 11.

PMID:
30539373
26.

Thoracic endografting increases cardiac afterload and leads to left ventricular hypertrophy in dogs.

Yamashita Y, Oishi Y, Motomatsu Y, Hirayama K, Harada T, Ushijima T, Fujita S, Kimura S, Sonoda H, Tatewaki H, Tanoue Y, Sunagawa G, Nishikawa T, Saku K, Shiose A.

Eur J Cardiothorac Surg. 2019 Apr 1;55(4):618-625. doi: 10.1093/ejcts/ezy402.

PMID:
30535346
27.

Significance of molecular classification of ependymomas: C11orf95-RELA fusion-negative supratentorial ependymomas are a heterogeneous group of tumors.

Fukuoka K, Kanemura Y, Shofuda T, Fukushima S, Yamashita S, Narushima D, Kato M, Honda-Kitahara M, Ichikawa H, Kohno T, Sasaki A, Hirato J, Hirose T, Komori T, Satomi K, Yoshida A, Yamasaki K, Nakano Y, Takada A, Nakamura T, Takami H, Matsushita Y, Suzuki T, Nakamura H, Makino K, Sonoda Y, Saito R, Tominaga T, Matsusaka Y, Kobayashi K, Nagane M, Furuta T, Nakada M, Narita Y, Hirose Y, Ohba S, Wada A, Shimizu K, Kurozumi K, Date I, Fukai J, Miyairi Y, Kagawa N, Kawamura A, Yoshida M, Nishida N, Wataya T, Yamaoka M, Tsuyuguchi N, Uda T, Takahashi M, Nakano Y, Akai T, Izumoto S, Nonaka M, Yoshifuji K, Kodama Y, Mano M, Ozawa T, Ramaswamy V, Taylor MD, Ushijima T, Shibui S, Yamasaki M, Arai H, Sakamoto H, Nishikawa R, Ichimura K; Japan Pediatric Molecular Neuro-Oncology Group (JPMNG).

Acta Neuropathol Commun. 2018 Dec 4;6(1):134. doi: 10.1186/s40478-018-0630-1.

28.

Antibiotics suppress colon tumorigenesis through inhibition of aberrant DNA methylation in an azoxymethane and dextran sulfate sodium colitis model.

Hattori N, Niwa T, Ishida T, Kobayashi K, Imai T, Mori A, Kimura K, Mori T, Asami Y, Ushijima T.

Cancer Sci. 2019 Jan;110(1):147-156. doi: 10.1111/cas.13880. Epub 2018 Dec 13.

29.

Concomitant carotid endarterectomy and aortic valve replacement in a patient with high risk of perioperative stroke.

Saito S, Nakamura T, Matsukura M, Origuchi N, Shigematsu K, Obitsu Y, Ushijima T.

Gen Thorac Cardiovasc Surg. 2018 Nov 15. doi: 10.1007/s11748-018-1035-6. [Epub ahead of print]

PMID:
30443815
30.

Comparison of cardiac energetics after transcatheter and surgical aortic valve replacements.

Yamashita Y, Tanoue Y, Sonoda H, Ushijima T, Kimura S, Oishi Y, Tatewaki H, Hiasa K, Arita T, Shiose A.

Interact Cardiovasc Thorac Surg. 2019 Apr 1;28(4):587-593. doi: 10.1093/icvts/ivy292.

PMID:
30364945
31.

DNA methylation marker to estimate the breast cancer cell fraction in DNA samples.

Ishihara H, Yamashita S, Fujii S, Tanabe K, Mukai H, Ushijima T.

Med Oncol. 2018 Sep 14;35(11):147. doi: 10.1007/s12032-018-1207-3.

PMID:
30218172
32.

Pancreatic Cancer Cell Fraction Estimation in a DNA Sample.

Ishihara H, Yamashita S, Amano R, Kimura K, Hirakawa K, Ueda T, Murakami Y, Tamori A, Tanabe K, Kawada N, Hagihara A, Ushijima T.

Oncology. 2018;95(6):370-379. doi: 10.1159/000491637. Epub 2018 Aug 27.

PMID:
30149376
33.
34.

Development of an integrated CRISPRi targeting ΔNp63 for treatment of squamous cell carcinoma.

Yoshida M, Yokota E, Sakuma T, Yamatsuji T, Takigawa N, Ushijima T, Yamamoto T, Fukazawa T, Naomoto Y.

Oncotarget. 2018 Jun 26;9(49):29220-29232. doi: 10.18632/oncotarget.25678. eCollection 2018 Jun 26.

35.

Methylation changes and aberrant expression of FGFR3 in Lewy body disease neurons.

Tsuchida T, Mano T, Koshi-Mano K, Bannai T, Matsubara T, Yamashita S, Ushijima T, Nagata K, Murayama S, Toda T, Tsuji S, Iwata A.

Brain Res. 2018 Oct 15;1697:59-66. doi: 10.1016/j.brainres.2018.06.017. Epub 2018 Jun 15.

PMID:
29909202
36.

Interaction between cardiac myosin-binding protein C and formin Fhod3.

Matsuyama S, Kage Y, Fujimoto N, Ushijima T, Tsuruda T, Kitamura K, Shiose A, Asada Y, Sumimoto H, Takeya R.

Proc Natl Acad Sci U S A. 2018 May 8;115(19):E4386-E4395. doi: 10.1073/pnas.1716498115. Epub 2018 Apr 23.

37.

Acute torrential mitral regurgitation during transcatheter aortic valve replacement: a case report.

Yamashita Y, Sonoda H, Ushijima T, Shiose A.

Surg Case Rep. 2018 Apr 18;4(1):35. doi: 10.1186/s40792-018-0446-z.

38.

Low dose cadmium upregulates the expression of von Willebrand factor in endothelial cells.

Wang X, Dong F, Wang F, Yan S, Chen X, Tozawa H, Ushijima T, Kapron CM, Wada Y, Liu J.

Toxicol Lett. 2018 Jun 15;290:46-54. doi: 10.1016/j.toxlet.2018.03.020. Epub 2018 Mar 20.

PMID:
29571895
39.

Predictive value of genetic analysis for pathological complete response to preoperative treatment in HER2 positive, HR negative early breast cancer (PASSION trial).

Yamaguchi T, Mukai H, Takahashi M, Hara F, Yamauchi C, Yamashita S, Ushijima T.

Jpn J Clin Oncol. 2018 Apr 1;48(4):388-391. doi: 10.1093/jjco/hyy024.

PMID:
29506214
40.

A case of gastric wall implantation caused by EUS-FNA 22 months after pancreatic cancer resection.

Yasumoto M, Okabe Y, Ishikawa H, Kisaki J, Akiba J, Naito Y, Ishida Y, Ushijima T, Tsuruta O, Torimura T.

Endosc Ultrasound. 2018 Jan-Feb;7(1):64-66. doi: 10.4103/eus.eus_58_17. No abstract available.

41.

Novel epigenetic markers for gastric cancer risk stratification in individuals after Helicobacter pylori eradication.

Maeda M, Yamashita S, Shimazu T, Iida N, Takeshima H, Nakajima T, Oda I, Nanjo S, Kusano C, Mori A, Moro H, Yamada H, Tsugane S, Sugiyama T, Sakai Y, Ushijima T.

Gastric Cancer. 2018 Sep;21(5):745-755. doi: 10.1007/s10120-018-0803-4. Epub 2018 Feb 9.

PMID:
29427040
42.

Double non-contiguous fractures in a patient with spondylo-epiphyseal dysplasia with spinal ankylosis treated with open and percutaneous spinal fixation technique: a case report.

Ushijima T, Kawaguchi K, Matsumoto T, Takagi M, Kondoh T, Nishimura G, Iida A, Ikegawa S, Haga N, Kato G.

BMC Res Notes. 2018 Feb 7;11(1):106. doi: 10.1186/s13104-018-3227-7.

43.

[Epigenetic Alterations in Gastrointestinal Cancers: Diagnostic and Therapeutic Applications].

Ushijima T, Maeda M, Kawachi A.

Gan To Kagaku Ryoho. 2018 Jan;45(1):1-7. Review. Japanese.

PMID:
29362296
44.

Genetic and epigenetic alterations in normal tissues have differential impacts on cancer risk among tissues.

Yamashita S, Kishino T, Takahashi T, Shimazu T, Charvat H, Kakugawa Y, Nakajima T, Lee YC, Iida N, Maeda M, Hattori N, Takeshima H, Nagano R, Oda I, Tsugane S, Wu MS, Ushijima T.

Proc Natl Acad Sci U S A. 2018 Feb 6;115(6):1328-1333. doi: 10.1073/pnas.1717340115. Epub 2018 Jan 22.

45.

MACON: a web tool for computing DNA methylation data obtained by the Illumina Infinium Human DNA methylation BeadArray.

Iida N, Okuda Y, Ogasawara O, Yamashita S, Takeshima H, Ushijima T.

Epigenomics. 2018 Mar;10(3):249-258. doi: 10.2217/epi-2017-0093. Epub 2018 Jan 18.

PMID:
29343101
46.

Analysis of DNA Methylation in Tissues Exposed to Inflammation.

Hattori N, Ushijima T.

Methods Mol Biol. 2018;1725:185-199. doi: 10.1007/978-1-4939-7568-6_16.

PMID:
29322419
47.

A case of pancreatic neuroendocrine tumor with multiple cystic components of various sizes.

Yasumoto M, Okabe Y, Sugiyama G, Naito Y, Nakayama M, Hisaka T, Ishikawa H, Horiuchi H, Kunou Y, Ushijima T, Ishida Y, Tsuruta O, Torimura T.

Clin J Gastroenterol. 2018 Feb;11(1):87-91. doi: 10.1007/s12328-017-0798-0. Epub 2017 Dec 21.

PMID:
29270782
48.

Erythema multiforme induced by regorafenib.

Matsunaga M, Ushijima T, Fukahori M, Tanikawa K, Miwa K.

J Gen Fam Med. 2017 Mar 24;18(2):90-91. doi: 10.1002/jgf2.29. eCollection 2017 Apr. No abstract available.

49.

The actin-organizing formin protein Fhod3 is required for postnatal development and functional maintenance of the adult heart in mice.

Ushijima T, Fujimoto N, Matsuyama S, Kan-O M, Kiyonari H, Shioi G, Kage Y, Yamasaki S, Takeya R, Sumimoto H.

J Biol Chem. 2018 Jan 5;293(1):148-162. doi: 10.1074/jbc.M117.813931. Epub 2017 Nov 20.

50.

A tissue microRNA signature that predicts the prognosis of breast cancer in young women.

Hironaka-Mitsuhashi A, Matsuzaki J, Takahashi RU, Yoshida M, Nezu Y, Yamamoto Y, Shiino S, Kinoshita T, Ushijima T, Hiraoka N, Shimizu C, Tamura K, Ochiya T.

PLoS One. 2017 Nov 15;12(11):e0187638. doi: 10.1371/journal.pone.0187638. eCollection 2017.

Supplemental Content

Loading ...
Support Center